Dunne Michael W. 4
4 · Iterum Therapeutics plc · Filed Aug 12, 2024
Insider Transaction Report
Form 4
Dunne Michael W.
Director
Transactions
- Exercise/Conversion
Warrants (right to buy)
2024-08-06+106,247→ 106,247 totalExercise: $1.21From: 2024-08-09Exp: 2025-08-09→ Ordinary Shares (53,123 underlying) - Exercise/Conversion
Subscription Rights (right to buy)
2024-08-06−212,494→ 0 totalExercise: $0.61From: 2024-07-22Exp: 2024-08-06→ Units - Exercise/Conversion
Ordinary Shares
2024-08-06+106,247→ 220,001 total - Exercise/Conversion
Warrants (right to buy)
2024-08-06+106,247→ 106,247 totalExercise: $1.21From: 2024-08-09Exp: 2029-08-09→ Ordinary Shares (106,247 underlying)
Footnotes (2)
- [F1]The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").
- [F2]The Reporting Person validly exercised 212,494 subscription rights to acquire 106,247 units composed of (i) 106,247 ordinary shares, (ii) 106,247 1-year warrants and (iii) 106,247 5-year warrants.